[Epidemiology of postpartum hemorrhages in the Umbrian population in the years 2006-2017.]

Epidemiologia delle emorragie post partum nella popolazione umbra nel periodo 2006-2017.

Journal

Recenti progressi in medicina
ISSN: 2038-1840
Titre abrégé: Recenti Prog Med
Pays: Italy
ID NLM: 0401271

Informations de publication

Date de publication:
Sep 2019
Historique:
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 26 3 2020
Statut: ppublish

Résumé

Postpartum haemorrhage (PPH) is one of the main causes of mortality and severe maternal morbidity and its incidence is increasing also in Western countries. Aim of this study is to estimate the incidence and the trend of PPH in the Umbrian population using the validated Umbrian health database and to identify possible determinants for the development of PPH. The source of the data was the regional Healthcare Database of the Umbria Region. The population of interest was represented by women who gave birth in Umbria between 2006 and 2017. The PPH was identified from the hospital data using the ICD-9-CM 666.x codes. Demographic data, principal and secondary diagnoses and data on maternal morbidity and blood component transfusion were collected. The incidence of PPH was calculated taking into account cases of PPH over the total number of births. The determinants of PPH, the associated morbidity and the variation in the severity of the PPH over time have been identified by logistic regression models. In Umbria, between 2006 and 2017, 93,403 births were registered (69% by vaginal delivery and 31% by caesarean section) and the rate of caesarean sections decreased by about 4%. The incidence of PPH increased three-fold during this period with an increase (p<0.001) of women with PPH who received transfusions. Regarding the caesarean sections, the PPH trend increased by 53% (p=0.3), while in the vaginal deliveries the PPHs increased by 233% (p<0.001). Logistic regression analysis showed that possible risk factors for the occurrence of PPH are maternal morbidity (OR 22.8, 95% CI 18.5-30.0), twin birth (OR 2.0, 95% CI 1.3-3.2) and antepartum haemorrhage (OR 5.7, 95% CI 3.1-10.4). The incidence of PPH has increased in recent years, while the morbidity associated with PPH has remained substantially unchanged. The study identified several risk factors responsible for PPH that can be used in the monitoring of pregnant women and for planning prevention strategies such as Patient Blood Management.

Identifiants

pubmed: 31593177
doi: 10.1701/3215.31934
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

412-419

Auteurs

Iosief Abraha (I)

Centro Regionale Sangue, Servizio Immunotrasfusionale, Azienda Ospedaliera di Perugia, Perugia - Direzione Regionale Salute, Regione Umbria, Perugia.

Alessandro Montedori (A)

Direzione Regionale Salute, Regione Umbria, Perugia.

Gianni Giovannini (G)

Direzione Regionale Salute, Regione Umbria, Perugia.

Francesco Cozzolino (F)

Direzione Regionale Salute, Regione Umbria, Perugia - Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati", Perugia.

Massimiliano Orso (M)

Direzione Regionale Salute, Regione Umbria, Perugia - Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati", Perugia.

Marcello De Giorgi (M)

Direzione Regionale Salute, Regione Umbria, Perugia.

David Franchini (D)

Direzione Regionale Salute, Regione Umbria, Perugia.

Gian Carlo Di Renzo (GC)

Clinica Ostetrica e Ginecologica, Policlinico, Università di Perugia.

Patrizio Angelozzi (P)

Ginecologia e Ostetricia, USL Umbria 2, Orvieto.

Marta Micheli (M)

Servizio Immunotrasfusionale, USL Umbria 2, Foligno.

Antonella Germani (A)

Servizio Immunotrasfusionale, USL Umbria 2, Foligno.

Danilo Carloni (D)

Anestesia e Rianimazione, USL Umbria 2, Foligno.

Augusto Scaccetti (A)

Servizio Immunotrasfusionale, Azienda Ospedaliera di Terni.

Gianluca Palmieri (G)

Servizio Immunotrasfusionale, Azienda Ospedaliera di Terni.

Marta Casali (M)

Anestesia e Rianimazione, Azienda Ospedaliera di Terni.

Chiara Maria Grazia Nenz (CMG)

Ginecologia e Ostetricia, Azienda Ospedaliera di Terni.

Elisabetta Gargano (E)

Terapia Intensiva e Rianimazione, USL Umbria 1, Perugia.

Michela Pazzaglia (M)

Ginecologia e Ostetricia, USL Umbria 1, Perugia.

Elisabetta Agea (E)

Servizio Immunotrasfusionale, USL Umbria 1, Perugia.

Claudia Moscetti (C)

Servizio Immunotrasfusionale, USL Umbria 1, Perugia.

Laura Berchicci (L)

Servizio Immunotrasfusionale, USL Umbria 1, Perugia.

Simonetta Tesoro (S)

Anestesia e Rianimazione, Azienda Ospedaliera di Perugia.

Nicola Albi (N)

Centro Regionale Sangue, Servizio Immunotrasfusionale, Azienda Ospedaliera di Perugia, Perugia.

Giorgio Epicoco (G)

Ginecologia e Ostetricia, Azienda Ospedaliera di Perugia.

Mauro Marchesi (M)

Centro Regionale Sangue, Servizio Immunotrasfusionale, Azienda Ospedaliera di Perugia, Perugia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH